A46 is expressed early during infection and binds to adaptor molecules downstream of Toll-like receptors (TLRs) and therefore inhibits the activation of downstream NF-κB, IRF3 and MAPK pathways [211,245,247,248]. This evidence concerns the gene NFKB1 and infection.